These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35589773)

  • 1. The hospital environment versus carriage: transmission pathways for third-generation cephalosporin-resistant bacteria in blood in neonates in a low-resource country healthcare setting.
    Kovacs D; Silago V; Msanga DR; Mshana SE; Seni J; Oravcova K; Matthews L
    Sci Rep; 2022 May; 12(1):8347. PubMed ID: 35589773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study.
    Aiken AM; Rehman AM; de Kraker MEA; Madrid L; Kebede M; Labi AK; Obeng-Nkrumah N; Nyamwaya B; Kagucia E; Cocker D; Kawaza K; Lester R; Iregbu KC; Medugu N; Nwajiobi-Princewill PI; Dramowski A; Sonda T; Hemed A; Fwoloshi S; Ojok D; Scott JAG; Whitelaw A;
    Lancet Infect Dis; 2023 Nov; 23(11):1280-1290. PubMed ID: 37454672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
    Lester R; Musicha P; van Ginneken N; Dramowski A; Hamer DH; Garner P; Feasey NA
    J Antimicrob Chemother; 2020 Mar; 75(3):492-507. PubMed ID: 31742611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales.
    Deelen JWT; Rottier WC; Giron Ortega JA; Rodriguez-Baño J; Harbarth S; Tacconelli E; Jacobsson G; Zahar JR; van Werkhoven CH; Bonten MJM;
    Clin Infect Dis; 2021 Dec; 73(11):e4475-e4483. PubMed ID: 32640024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1495-1502. PubMed ID: 32221726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.
    Lin WP; Huang YS; Wang JT; Chen YC; Chang SC
    BMC Infect Dis; 2019 Mar; 19(1):245. PubMed ID: 30866828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study.
    Dramowski A; Ong'ayo G; Rehman AM; Whitelaw A; Labi AK; Obeng-Nkrumah N; Ndir A; Magwenzi MT; Onyedibe K; Wolkewitz M; de Kraker MEA; Scott JAG; Aiken AM;
    JAC Antimicrob Resist; 2021 Mar; 3(1):dlaa130. PubMed ID: 34223079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymicrobial bloodstream infections a risk factor for mortality in neonates at the national hospital, Tanzania: A case-control study.
    Manyahi J; Joachim A; Msafiri F; Migiro M; Mwingwa A; Kasubi M; Naburi H; Majigo MV
    PLoS One; 2024; 19(4):e0302076. PubMed ID: 38625965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality associated with third-generation cephalosporin resistance in Enterobacteriaceae bloodstream infections at one South African hospital.
    Dramowski A; Aiken AM; Rehman AM; Snyman Y; Reuter S; Grundmann H; Scott JAG; de Kraker MEA; Whitelaw A
    J Glob Antimicrob Resist; 2022 Jun; 29():176-184. PubMed ID: 35283332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interspecies differences in clinical characteristics and risk factors for third-generation cephalosporin resistance between Escherichia coli and Klebsiella pneumoniae bloodstream infection in patients with liver cirrhosis.
    Ham SY; Jung H; Song KH; Jeong H; Jung J; Moon SM; Park JS; Kim NH; Jang ES; Kim JW; Jeong SH; Kim ES; Kim HB
    Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1459-1465. PubMed ID: 36227508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperacillin/tazobactam-resistant, cephalosporin-susceptible
    Edwards T; Heinz E; van Aartsen J; Howard A; Roberts P; Corless C; Fraser AJ; Williams CT; Bulgasim I; Cuevas LE; Parry CM; Roberts AP; Adams ER; Mason J; Hubbard ATM
    Microb Genom; 2022 Apr; 8(4):. PubMed ID: 35404783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.
    MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
    Antimicrob Resist Infect Control; 2021 Sep; 10(1):131. PubMed ID: 34488891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission Dynamics of Hyper-Endemic Multi-Drug Resistant
    Smit PW; Stoesser N; Pol S; van Kleef E; Oonsivilai M; Tan P; Neou L; Turner C; Turner P; Cooper BS
    Front Microbiol; 2018; 9():1197. PubMed ID: 29951041
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
    Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
    BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
    Marquet A; Vibet MA; Caillon J; Javaudin F; Chapelet G; Montassier E; Batard E
    Microb Drug Resist; 2018 Sep; 24(7):987-994. PubMed ID: 29489447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal bloodstream infections in a pediatric hospital in Vietnam: a cohort study.
    Kruse AY; Thieu Chuong do H; Phuong CN; Duc T; Graff Stensballe L; Prag J; Kurtzhals J; Greisen G; Pedersen FK
    J Trop Pediatr; 2013 Dec; 59(6):483-8. PubMed ID: 23868576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Rates of Human Fecal Carriage of mcr-1-Positive Multidrug-Resistant Enterobacteriaceae Emerge in China in Association With Successful Plasmid Families.
    Zhong LL; Phan HTT; Shen C; Vihta KD; Sheppard AE; Huang X; Zeng KJ; Li HY; Zhang XF; Patil S; Crook DW; Walker AS; Xing Y; Lin JL; Feng LQ; Doi Y; Xia Y; Stoesser N; Tian GB
    Clin Infect Dis; 2018 Feb; 66(5):676-685. PubMed ID: 29040419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular ecology and risk factors for third-generation cephalosporin-resistant Escherichia coli carriage by dogs living in urban and nearby rural settings.
    Sealey JE; Hammond A; Mounsey O; Gould VC; Reyher KK; Avison MB
    J Antimicrob Chemother; 2022 Aug; 77(9):2399-2405. PubMed ID: 35858661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of and Risk Factors for Third-Generation Cephalosporin-Resistant
    Cheng J; Liu Y; Li S; Pu K; Yang L; Tan L
    Infect Drug Resist; 2024; 17():543-550. PubMed ID: 38352624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of carriage of multidrug-resistant bacteria in dogs and cats in veterinary care and co-carriage with their owners.
    Dazio V; Nigg A; Schmidt JS; Brilhante M; Campos-Madueno EI; Mauri N; Kuster SP; Brawand SG; Willi B; Endimiani A; Perreten V; Schuller S
    One Health; 2021 Dec; 13():100322. PubMed ID: 34522760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.